Glaucoma- POAG Flashcards
Normal range for IOP
13-21 mmHg
NT glaucoma classification
Normal IOP with glaucomatous changes
Glaucoma classification
Elevated IOP with glaucomatous changes
Ocular HTN classification
Elevated IOP with no glaucomatous changes
Risk factors for POAG
Age (>60, >40 for Black patients) Elevated IOP (>21) Ethnicity (Blacks and Hispanics) Increased cup-to-disk ratio Family history Central corneal thickness (thinner is at an increased risk) Ocular perfusion pressure (lower is at an increased risk) T2DM Myopia (near-sightedness)
Who to treat for glaucoma
All patients with elevated IOP AND confirmed disc changes/field defects
All patients with ocular HTN AND at least 2 risk factors
All patients with NT glaucoma AND documented progression of visual field loss
Glaucoma treatment goals
PRESERVE THE NERVE
Lower IOP ≥25% below pretreatment IOP
Surgery for glaucoma
Mainstay of treatment (more effective at lowering IOP) but more expensive and invasive
QOL differences with glaucoma surgery
Increased risk of cataract formation, loss of visual acuity and local eye Sx infrequent but higher in surgical patients
How to choose a glaucoma med
Choose a drug and regiment that have minimal impact on QOL and vision
Prostaglandin analog drugs
Bimatoprost, latanoprost, latanoprostene bunod
How much do prostaglandin analogs lower IOP?
25-33%
Bimatoprost pearls
Best efficacy, but worst side effects in generic 0.03% formulation. Lumigan is 0.1% and has a better side effect profile but still brand name regardless
Latanoprost pearl
Most popular generic
PA ADEs
Red eyes, hypertrichosis (eyelash growth), systemic infection, headache, eye color changes (iris)
PA CIs
macular edema, iritis, uveitis, keratitis
Beta-blocker drugs
Betaxolol, cartelol, levobunolol, metiprandolol, timolol